September 1, 2016
(The Economist) – FOR THOSE who can afford it, in vitro fertilisation (IVF) can make a dream come true. As with any other expensive medical treatment, the lucky recipients are much more likely to live in rich countries. In 2010, for example, the number of IVF cycles per million people in Denmark was 28 times the figure in India, according to estimates published earlier this year by the International Committee Monitoring Assisted Reproductive Technologies (ICMART). Within rich nations, a crucial factor determining the prevalence of IVF is government generosity.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.